Core Laboratories (CLB) Gross Margin (2022 - 2026)

Core Laboratories' Gross Margin history runs 5 years deep, the most recent figure standing at 37.51% for Q1 2026.

• On a quarterly basis, Gross Margin fell 344.0% year-over-year to 37.51% in Q1 2026; TTM through Mar 2026 was 85.97%, a 4322.0% increase from a year earlier, with the FY2025 full-year figure at 78.09%, up 3484.0% from the prior year.
• Gross Margin fell to 37.51% in Q1 2026 per CLB's latest filing, from 177.07% in the prior quarter.
• Across five years, Gross Margin topped out at 177.07% in Q4 2025 and bottomed at 37.51% in Q1 2026.
• The 5-year median for Gross Margin is 45.65% (2022), against an average of 69.99%.
• Across the five-year window, Gross Margin sank 12929 bps in 2024 and jumped 13365 bps in 2025, its largest moves.
• Year by year, Gross Margin stood at 76.36% in 2022, then surged by 126 bps to 172.7% in 2023, then slumped by 75 bps to 43.41% in 2024, then jumped by 308 bps to 177.07% in 2025, then tumbled by 79 bps to 37.51% in 2026.
• Per Business Quant, the three latest CLB Gross Margin figures stand at 37.51% (Q1 2026), 177.07% (Q4 2025), and 77.69% (Q3 2025).